Erfolgreich hinzugefügt!
Kursdaten 
Chart
News + Analysen
Fundamental
Unternehmen
Derivate
Aktion
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 91,06 |
| Sandoz Family Foundation | 3,61 |
| Novartis AG | 3,05 |
| UBS Asset Management Switzerland AG | 2,30 |
| Novartis Foundation For Employee Participation | 2,14 |
| Vanguard Total International Stock Index Fund | 1,18 |
| Vanguard Health Care Fund | 0,83 |
| CSIF (CH) Umbrella - Eq. Switzerland Total Market Index Blue | 0,77 |
| Vanguard Developed Markets Index Fund | 0,56 |
| Vanguard Wellington Fund | 0,55 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 118.393 | 121.597 | 125.161 | 103.914 | 105.794 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,40 | 0,40 | 0,41 | 0,45 | 0,43 |
Bilanz (in Mio. EUR) - Aktiva
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 25.339 | 27.489 | 35.058 | 28.570 | 26.229 |
| Summe Anlagevermögen | 100.247 | 99.977 | 109.132 | 81.944 | 83.492 |
| Summe Aktiva | 132.519 | 129.833 | 143.578 | 114.665 | 116.848 |
Bilanz (in Mio. EUR) - Passiva
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 24.191 | 27.700 | 31.634 | 28.225 | 33.462 |
| Summe Fremdkapital | 56.403 | 57.498 | 66.003 | 60.872 | 66.759 |
| Summe Eigenkapital | 76.115 | 72.334 | 77.575 | 53.793 | 50.090 |
| Summe Passiva | 132.519 | 129.833 | 143.578 | 114.665 | 116.848 |
Adresse
| Lichtstrasse 35, 4056 Basel | |
| Telefon | +41 (61) 324-11-11 |
| Fax | +41 (61) 3248001 |
| Internet | http://www.novartis.com |
Management
|
Andreas von Planta
Independent Non-Executive Director |
|
Ann Marie Fudge
Independent Non-Executive Director |
|
Bridgette P. Heller
Director |
|
Charles L. Sawyers
Independent Non-Executive Director |
|
Charlotte Pamer-Wieser
Secretary |
|
Enrico Cipro Vanni
Vice Chairman |
|
Frans van Houten
Independent Non-Executive Director |
|
Hans Jörg Reinhardt
Independent Non-Executive Chairman |
|
Harry Werner Kirsch
Chief Financial Officer |
|
John Tsai
Chief Medical Officer |
|
Klaus Moosmayer
Chief Ethics Risk & Compliance Officer |
|
Marco Gadola
Senior Auditor |
|
Mary Elizabeth Doherty
Independent Non-Executive Director |
|
Nancy C. Andrews
Independent Non-Executive Director |
|
Patrice Bula
Director |
|
Samir Shah
Global Head-Investor Relations |
|
Shannon Thyme Klinger
Chief Legal Officer |
|
Simon E. Moroney
Director |
|
Srikant T. Madhav Datar
Independent Non-Executive Director |
|
Steven Baert
Chief People & Organization Officer |
|
Ton Büchner
Independent Non-Executive Director |
|
Vasant Narasimhan
Chief Executive Officer |
|
William Thomas Winters
Independent Non-Executive Director |
